Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,819 across all filing types
Latest filing 2022-03-29 Foreign Filer Report
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
6-K
Foreign Filer Report
2022-03-29 English
Director's Dealing 2022
Director's Dealing Classification · 100% confidence The document is titled "Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons" and explicitly states it discloses data in accordance with Article 19 of Regulation No. 596/2014 on Market Abuse. This regulation mandates the disclosure of transactions conducted by persons discharging managerial responsibilities (PDMRs). This directly corresponds to the definition of Director's Dealing (insider trades by executives/directors). Although the document is short and includes an attachment, the core content is the disclosure itself, not just an announcement of a report. The specific nature of the content (managerial employee transactions) overrides the general 'Report Publication Announcement' possibility, making 'Director's Dealing' the most accurate classification.
2022-03-29 English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Director's Dealing Classification · 100% confidence The document is a formal notification of transactions in company shares by a member of the Board of Directors (Elizabeth O’Farrell). It explicitly cites Regulation No. 596/2014 on Market Abuse, which is the standard regulatory framework for reporting insider/director dealings. The content details the nature of the transaction (grant of Restricted Stock Units), the price, and the volume, which aligns perfectly with the definition of a Director's Dealing (DIRS) filing.
2022-03-29 English
6-K
Foreign Filer Report
2022-03-29 English
6-K
Foreign Filer Report
2022-03-14 English
6-K
Foreign Filer Report
2022-03-09 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.